0001437749-21-007952.txt : 20210401 0001437749-21-007952.hdr.sgml : 20210401 20210401093334 ACCESSION NUMBER: 0001437749-21-007952 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210330 FILED AS OF DATE: 20210401 DATE AS OF CHANGE: 20210401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Simpson Jennifer K. CENTRAL INDEX KEY: 0001545253 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39468 FILM NUMBER: 21796318 MAIL ADDRESS: STREET 1: C/O DELCATH SYSTEMS, INC. STREET 2: 810 SEVENTH AVENUE, SUITE 3505 CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Panbela Therapeutics, Inc. CENTRAL INDEX KEY: 0001029125 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870543922 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 712 VISTA BLVD #305 CITY: WACONIA STATE: MN ZIP: 55387 BUSINESS PHONE: 9524791196 MAIL ADDRESS: STREET 1: 712 VISTA BLVD #305 CITY: WACONIA STATE: MN ZIP: 55387 FORMER COMPANY: FORMER CONFORMED NAME: Sun BioPharma, Inc. DATE OF NAME CHANGE: 20150911 FORMER COMPANY: FORMER CONFORMED NAME: Cimarron Medical, Inc. DATE OF NAME CHANGE: 20150602 FORMER COMPANY: FORMER CONFORMED NAME: CIMARRON SOFTWARE INC DATE OF NAME CHANGE: 19961217 4 1 rdgdoc.xml FORM 4 X0306 4 2021-03-30 0001029125 Panbela Therapeutics, Inc. PBLA 0001545253 Simpson Jennifer K. 712 VISTA BLVD #305 WACONIA MN 55387 1 1 President and CEO Employee Stock Option (right to buy) 4.09 2021-03-30 4 A 0 170000 0 A 2031-03-30 Common Stock 170000 170000 D The stock option is exercisable in three substantially equal installments on the first, second and third anniversaries of the date of grant (March 30, 2022, 2023 and 2024). /s/ Joshua L. Colburn, Attorney-in-Fact 2021-04-01